Haochen Lin , Zheng Li , Ivan V. Zelepukin , Sergey M. Deyev , Xiangliang Yang , Zifu Li
{"title":"Effects of nanoparticle physicochemical properties on macrophage polarization","authors":"Haochen Lin , Zheng Li , Ivan V. Zelepukin , Sergey M. Deyev , Xiangliang Yang , Zifu Li","doi":"10.1016/j.jconrel.2025.114215","DOIUrl":null,"url":null,"abstract":"<div><div>Tumor-associated macrophages (TAMs) are crucial in regulating tumor immune microenvironment (TIME), tumor development and tumor therapy. Nanoparticles, as traditional tumor targeting drug delivery systems, of which the intrinsic immunomodulatory potential has been gradually explored by modulating physicochemical properties. This review systematically summarizes advancements in polarizing macrophages by regulating physicochemical properties of nanoparticles including size, morphology, surface properties, stiffness, and other factors. Furthermore, the polarization mechanisms are expounded via biochemical and mechanical signaling pathways. Size of nanoparticles affects macrophage polarization through lysosomal stress and membrane interaction; morphology of nanoparticles impacts macrophage polarization through inducing membrane curvature or modulating cellular metabolism; surface properties of nanoparticles effects macrophage polarization through enhancing nanoparticle binding ability to cell membrane; stiffness of nanoparticles polarize macrophages through activating mechanosensitive ion channels and inducing deformation of membrane; other properties of nanoparticles effects macrophage polarization via glycolysis, oxidative phosphorylation, etc. These outcomes contribute to the optimization of nanomedicine physicochemical properties for tumor immunotherapy by regulating polarization of TAMs and reshaping the immunosuppressive TIME, thereby driving the development of precision immuno-oncology for various malignancies.</div></div>","PeriodicalId":15450,"journal":{"name":"Journal of Controlled Release","volume":"387 ","pages":"Article 114215"},"PeriodicalIF":11.5000,"publicationDate":"2025-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Controlled Release","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0168365925008272","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0
Abstract
Tumor-associated macrophages (TAMs) are crucial in regulating tumor immune microenvironment (TIME), tumor development and tumor therapy. Nanoparticles, as traditional tumor targeting drug delivery systems, of which the intrinsic immunomodulatory potential has been gradually explored by modulating physicochemical properties. This review systematically summarizes advancements in polarizing macrophages by regulating physicochemical properties of nanoparticles including size, morphology, surface properties, stiffness, and other factors. Furthermore, the polarization mechanisms are expounded via biochemical and mechanical signaling pathways. Size of nanoparticles affects macrophage polarization through lysosomal stress and membrane interaction; morphology of nanoparticles impacts macrophage polarization through inducing membrane curvature or modulating cellular metabolism; surface properties of nanoparticles effects macrophage polarization through enhancing nanoparticle binding ability to cell membrane; stiffness of nanoparticles polarize macrophages through activating mechanosensitive ion channels and inducing deformation of membrane; other properties of nanoparticles effects macrophage polarization via glycolysis, oxidative phosphorylation, etc. These outcomes contribute to the optimization of nanomedicine physicochemical properties for tumor immunotherapy by regulating polarization of TAMs and reshaping the immunosuppressive TIME, thereby driving the development of precision immuno-oncology for various malignancies.
期刊介绍:
The Journal of Controlled Release (JCR) proudly serves as the Official Journal of the Controlled Release Society and the Japan Society of Drug Delivery System.
Dedicated to the broad field of delivery science and technology, JCR publishes high-quality research articles covering drug delivery systems and all facets of formulations. This includes the physicochemical and biological properties of drugs, design and characterization of dosage forms, release mechanisms, in vivo testing, and formulation research and development across pharmaceutical, diagnostic, agricultural, environmental, cosmetic, and food industries.
Priority is given to manuscripts that contribute to the fundamental understanding of principles or demonstrate the advantages of novel technologies in terms of safety and efficacy over current clinical standards. JCR strives to be a leading platform for advancements in delivery science and technology.